Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment. [electronic resource]
Producer: 20120508Description: 33-42 p. digitalISSN:- 1464-5157
- Antigen Presentation
- Antineoplastic Agents, Alkylating -- pharmacology
- Cell Line, Tumor
- Cell Survival
- Green Fluorescent Proteins -- immunology
- Hot Temperature
- Humans
- Ifosfamide -- pharmacology
- Interferon-gamma -- immunology
- Monophenol Monooxygenase -- genetics
- Sarcoma -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Transduction, Genetic
- Tumor Cells, Cultured
- Vaccinia -- immunology
- Vaccinia virus -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.